Press Releases May 29, 2026 08:00 AM

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

PetMed Express Schedules Q4 and Fiscal Year 2026 Earnings Report and Conference Call for June 2, 2026

By Nina Shah PETS

PetMed Express, Inc., a leading online pet pharmacy, announced it will release its financial results for the fourth quarter and fiscal year ended March 31, 2026, on June 2, 2026 after market close. The company will also host a live conference call and webcast the same day to discuss these results.

PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
PETS

Key Points

  • PetMed Express operates a direct-to-consumer online pet pharmacy licensed across all 50 states with a focus on pet health products including pharmaceuticals, compounded medications, and supplements.
  • The company will report quarterly and annual financial results on June 2, 2026, followed by a conference call, indicating transparency and investor engagement.
  • PetMed Express's offerings target pet owners and veterinarians, impacting the pet healthcare and pharmaceutical e-commerce sectors.

DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day.

Date: Tuesday, June 2, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 4Q Earnings Webcast

A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through June 16, 2026.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13760873

About PetMed Express, Inc.

Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PETS family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.

Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
[email protected]


Risks

  • Financial results could be negatively impacted by changing consumer demand or supply chain disruptions in the pharmaceutical and pet health sectors.
  • The company's revenue and growth may face risks from competitive pressures in the online pet pharmacy market.
  • Regulatory changes affecting pharmaceutical products could create compliance costs or limit product offerings in the pet healthcare sector.

More from Press Releases

LiqTech International Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Jun 4, 2026 Correction: Keystone Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option Jun 4, 2026 Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026